The management of schizophrenia: focus on extended-release quetiapine fumarate

QR Code

The management of schizophrenia: focus on extended-release quetiapine fumarate

Joseph Peuskens Universitair Psychiatrisch Centrum KU Leuven, Campus St Jozef Kortenberg, Kortenberg, Belgium Abstract: Effective management of schizophrenia remains a significant clinical challenge. While antipsychotic medications have proven efficacy in this disease, there remains an opportunity t...

Description complète

Enregistré dans:

Détails bibliographiques
Auteur principal:	Peuskens J
Format:	article
Langue:	EN
Publié:	Dove Medical Press 2011
Sujets:	Neurosciences. Biological psychiatry. Neuropsychiatry RC321-571 Neurology. Diseases of the nervous system RC346-429
Accès en ligne:	https://doaj.org/article/0a7a9e29149b401290c9eac1d3864aa3
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

Update on extended release quetiapine fumarate in schizophrenia and bipolar disorders
par: El-Khalili N
Publié: (2012)

Role of extended release quetiapine in the management of bipolar disorders
par: Rayan K Al Jurdi, et autres
Publié: (2010)

Effects of once-daily extended release quetiapine fumarate on patient-reported outcomes in patients with generalized anxiety disorder
par: Endicott J, et autres
Publié: (2012)

Direct and indirect effects of paliperidone extended-release tablets on negative symptoms of schizophrenia
par: Ibrahim Turkoz, et autres
Publié: (2008)

Reduced serum paraoxonase 1 (PON1) activity in patients with schizophrenia treated with olanzapine but not quetiapine
par: &Uuml;nsal C, et autres
Publié: (2013)

Is quetiapine suitable for treatment of acute schizophrenia with catatonic stupor? A case series of 39 patients
par: Yoshimura B, et autres
Publié: (2013)

Update on the management of symptoms in schizophrenia: focus on amisulpride
par: Ann M Mortimer
Publié: (2009)

The social functional outcome of being naturalistically treated with paliperidone extended-release in patients with schizophrenia
par: Nakagawa R, et autres
Publié: (2015)

Management of obsessive-compulsive disorder with fluvoxamine extended release
par: L&iacute;dia Ordacgi, et autres
Publié: (2009)

Quetiapine monotherapy for bipolar depression
par: Michael E Thase
Publié: (2008)

Paliperidone extended-release tablets in Chinese patients with schizophrenia: meta-analysis of randomized controlled trials
par: Cai SL, et autres
Publié: (2015)

Review of levetiracetam, with a focus on the extended release formulation, as adjuvant therapy in controlling partial-onset seizures
par: Carol M Ulloa, et autres
Publié: (2009)

New developments in the management of major depressive disorder and generalized anxiety disorder: role of quetiapine
par: Bernhard T Baune
Publié: (2008)

An open-label, prospective study to evaluate social function and overall improvement of extended-release paliperidone treatment in Thai schizophrenia patients
par: Charnsil C, et autres
Publié: (2013)

A review of quetiapine in combination with antidepressant therapy in patients with depression
par: Ella J Daly, et autres
Publié: (2007)

Effects of quetiapine on sleep architecture in patients with unipolar or bipolar depression
par: Laura Gedge, et autres
Publié: (2010)

Update on quetiapine in the treatment of bipolar disorder: results from the BOLDER studies
par: Prashant Gajwani, et autres
Publié: (2007)

Role of paliperidone extended-release in treatment of schizoaffective disorder
par: Carla M Canuso, et autres
Publié: (2010)

The role of paliperidone extended release for the treatment of bipolar disorder
par: Marino J, et autres
Publié: (2012)

Quetiapine mitigates the ethanol-induced oxidative stress in brain tissue, but not in the liver, of the rat
par: Han JH, et autres
Publié: (2015)

A randomized controlled trial of quetiapine for psychosis in Parkinson&rsquo;s disease
par: Paul Shotbolt, et autres
Publié: (2009)

Efficacy, safety, and potential of extended-release lamotrigine in the treatment of epileptic patients
par: Barbara Błaszczyk, et autres
Publié: (2010)

Impact of extended-release dalfampridine on walking ability in patients with multiple sclerosis
par: Hayes KC
Publié: (2011)

Risperidone, quetiapine, and olanzapine adjunctive treatments in major depression with psychotic features: a comparative study
par: Gabriel A
Publié: (2013)

Extended-release divalproex in bipolar and other psychiatric disorders: A comprehensive review
par: Steven C Stoner, et autres
Publié: (2007)

Dalfampridine extended release tablets: 1 year of postmarketing safety experience in the US
par: Jara M, et autres
Publié: (2013)

Profile of guanfacine extended release and its potential in the treatment of attention-deficit hyperactivity disorder
par: Martinez-Raga J, et autres
Publié: (2015)

Emerging role of sertindole in the management of schizophrenia
par: Stephanie L Cincotta, et autres
Publié: (2010)

Critical appraisal of lurasidone in the management of schizophrenia
par: Caccia S, et autres
Publié: (2012)

Retrospective analysis of factors associated with quetiapine dosage in the acute and subsequent six-month maintenance treatment of bipolar disorders
par: Zhang L, et autres
Publié: (2013)

Efficacy of quetiapine in patients with bipolar I and II depression: a multicenter, prospective, open-label, observational study
par: Jeong JH, et autres
Publié: (2013)

Clinical utility of the risperidone formulations in the management of schizophrenia
par: Madaan V, et autres
Publié: (2011)

An open-label, flexible-dose study of paliperidone extended-release in Chinese patients with first-onset psychosis
par: Si TM, et autres
Publié: (2015)

Effects of paliperidone extended release on hostility among Thai patients with schizophrenia
par: Jariyavilas A, et autres
Publié: (2017)

Current approaches to treatments for schizophrenia spectrum disorders, part II: psychosocial interventions and patient-focused perspectives in psychiatric care
par: Chien WT, et autres
Publié: (2013)

The role of family therapy in the management of schizophrenia: challenges and solutions
par: Caqueo-Urízar A, et autres
Publié: (2015)

Differential diagnoses and management strategies in patients with schizophrenia and bipolar disorder
par: A Carlo Altamura, et autres
Publié: (2008)

Update on the management of Lennox-Gastaut syndrome with a focus on rufinamide
par: Carl&nbsp;E Stafstrom
Publié: (2009)

Soccer practice as an add-on treatment in the management of individuals with a diagnosis of schizophrenia
par: Battaglia G, et autres
Publié: (2013)

Management of attention-deficit hyperactivity disorder in adults: focus on methylphenidate hydrochloride
par: Rajasree Nair, et autres
Publié: (2009)